moderna covid - Search News

News

Moderna to cut 10% of global workforce

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

Benzinga · 22h

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

CNBC on MSN · 23h

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by the end of the year.

Moderna Announces 10% Layoffs Ahead Of Q2 Report

CBS News on MSN · 19h

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce.

WCVB Channel 5 Boston · 19h

Cambridge-based Moderna announces plan to cut workforce by 10%

Massachusetts-based vaccine maker Moderna on Thursday announced plans to cut its workforce by approximately 10%. Moderna CEO Stéphane Bancel notified employees of the decision. His memo explained that the company is committed to cutting operating expenses by approximately $1.

Stocktwits on MSN · 19h

Moderna Announces 10% Layoffs Ahead Of Q2 Report: Retail Now Eyes ‘Good Enough’ Earnings

Vaccine maker Moderna (MRNA) on Thursday said that the company will reduce its headcount by about 10% globally to shrink its workforce to fewer than 5,000 individuals by the end of the year. The announcement comes ahead of the company's second-quarter (Q2) earnings,

17h

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

28mon MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

15h

Moderna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...

BioPharma Dive7h

Moderna to lay off 10% of workforce in ‘difficult but necessary step’

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

BioSpace9d

After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Fierce Pharma20h

Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end

Despite efforts to spare employees by scaling back R&D and reducing operating costs by roughly $1.5 billion over the next two ...

The HR Digest54m

Moderna Layoffs Come for 10% of the Workforce Despite “Best Efforts”

The Moderna layoffs are aimed at cutting costs amid declining vaccine sales and a shifting regulatory landscape.

23hon MSN

Pandemic darlings Moderna, BioNTech are now on two different paths

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

6don MSN

Down 74% Over the Past Year, Is Moderna Stock a Buy?

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results